Waymo Robotaxis Now Operating in 25 Major Cities

Waymo Robotaxis Now Operating in 25 Major Cities

Alphabet's Waymo expands its fully autonomous taxi service to 25 cities, completing over 1 million rides per day with zero accidents attributed to the self-driving system.

Solar Paint Achieves 30% Efficiency: Every Building Can Generate Power

Solar Paint Achieves 30% Efficiency: Every Building Can Generate Power

Breakthrough in perovskite solar cell technology results in paintable solar panels with 30% efficiency, making it economically viable to turn any surface into a power generator.

Boston Dynamics Robots Now Working in Amazon Warehouses

Boston Dynamics Robots Now Working in Amazon Warehouses

Amazon deploys 10,000 Boston Dynamics robots across its fulfillment centers, increasing package processing speed by 300% while reducing workplace injuries by half.

Google's Project Starline: 3D Video Calls Without Headsets

Google's Project Starline: 3D Video Calls Without Headsets

Google's breakthrough in light field display technology enables life-like 3D video conversations without VR headsets, making remote communication feel as natural as sitting across a table.

NVIDIA H200 GPU Breaks AI Training Records

NVIDIA H200 GPU Breaks AI Training Records

NVIDIA's latest datacenter GPU trains large language models 5x faster than previous generation, enabling researchers to develop more sophisticated AI models while reducing energy consumption by 40%.

Ethereum 3.0 Launches: 100,000 Transactions Per Second Achieved

Ethereum 3.0 Launches: 100,000 Transactions Per Second Achieved

The long-awaited Ethereum upgrade delivers on its promise of scalability, processing 100,000 transactions per second while maintaining decentralization and reducing gas fees to pennies.

Revolutionary Cancer Treatment: AI Discovers Personalized Drug Combinations

Revolutionary Cancer Treatment: AI Discovers Personalized Drug Combinations

DeepMind's AlphaFold 3 identifies optimal drug combinations for individual cancer patients based on their genetic profile, leading to 80% higher remission rates in clinical trials.